Will Intercept Drop OCA For NASH Following Negative FDA Panel Review?

 
• By Joseph Haas
  
No vote
FDA advisory panel decisively votes against recommending approval of OCA for NASH • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from New Products

More from Scrip